Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2020

4190047/2020 - Anastrazol + Bicalutamida + Darunavir (P259-2019-293)

Contract value
€2,607.11
Signed on
16 January 2020
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 6546751

PUBLISHED SUBJECT

P259-2019-293 Aquisição de medicamentos no âmbito da agregação centralizada de 2020 para as instituições do SNS

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Setúbal, Barreiro; Portugal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
ACCORD HEALTHCARE UNIPESSOAL LDA. · Tax ID 508622263
Bidder
FRESENIUS KABI PHARMA PORTUGAL, LDA · Tax ID 504293753
Bidder
HIKMA FARMACÊUTICA (PORTUGAL) SA. · Tax ID 502266791
Bidder
Sandoz · Tax ID 506985261

HOW MUCH AND WHEN

Values and timeline

Contract price
€2,607.11
Procedure base price
€2,335,260.82
Total effective price
€2,607.11
Publication date
7 May 2020
Award date
16 January 2020
Signing date
16 January 2020
Performance period
365 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Preço ou custo
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
CP 2019/61 - Medicamentos diversos
Centralised procedure
Yes
Environmental criterion
No
Notice
Not stated
Procedure identifier
4293095

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts